Doctors Express Concern Over Covishield Vaccine Safety Amid AstraZeneca’s Acknowledgement of Blood Clot Risks

Dr. Tarun Kothari, a radiologist and activist, highlighted the apparent discrepancy between the government’s promotion of COVID-19 vaccines as “safe and effective” and the rising number of reported cases of adverse events post-vaccination. He emphasized the importance of investigating these events scientifically and invoking epidemiology to ensure public safety.

Dr. Sujata Mittal, a gynecologist and oncologist, emphasized the lack of awareness surrounding vaccine injuries in India. She noted that thousands of women had reported abnormalities in their menstrual cycles, which were later confirmed as a side effect of the vaccine in a study published in September 2022.

The AIM has been collecting data on COVID-19 vaccine-related deaths reported in the media and on social media platforms since the commencement of vaccination drives in 2021. Dr. Kothari lamented the government’s failure to respond to their requests for investigations into these deaths and vaccine-related debilitations.

The AIM demanded compensation for all victims of COVID-19 vaccines and their families, with the involvement of vaccine manufacturers in the compensation mechanism. They also called for the establishment of fast-track and vaccine courts to ensure swift justice for vaccine-injured individuals and their families.

Furthermore, Dr. Mittal stressed the need for active surveillance and monitoring mechanisms to detect vaccine adverse events early and advocated for the creation and dissemination of early treatment protocols to save lives.

The withdrawal of AstraZeneca’s COVID-19 vaccine, known as Covishield in India, has prompted global attention. AstraZeneca stated that the withdrawal was initiated due to a surplus of updated vaccines available since the pandemic.